Company News

Ex-FDA Commissioner joins Pfizer Scott Gottlieb will also be a part of the Regulatory and Compliance Committee and the Science and Technology Committee of Pfizer’s Board Newcomer Quell Therapeutics appoints Iain McGill as CEO The company was founded in March 2019, in a partnership between prominent experts from King's College London, University College London, and Hannover Medical School Dr Bartu Ahiska is new Senior VP at Oxford BioDynamics In his new role Ahiska will spearhead the commercialisation of the group’s EpiSwitch technology platform Domain Therapeutics adds Sylvie Ryckebusch to Board Ryckebusch joins Domain from Merck Serono Symbiosis Pharmaceutical Services appoints Helen Caddy-Leach Caddy-Leach will take on the role of Business Development Manager to support growing US presence MG America appoints Janice Wortham as Regional Sales Manager Wortham will cover the Processing division covering some on the most important pharma stronghold in the US ReViral appoints Alex Sapir as new CEO Sapir will be based at North Carolina’s Research Triangle Park alongside the company’s new CMO, Seth Hetherington Uhlmann Packaging Systems has new US Regional Sales Manager Markus Leuprecht will take over leading the Southwestern US and Texas Lyndra Therapeutics has new CEO Dr Patricia Hurter will begin her new post on 3 September TraceLink appoints four new Board Members New appointments include prominent supply chain industry leaders and former industry analysts; Roddy Martin, John Bermudez, Kevin Young and Steve Collins Ulrich Platte is new CFO of eTheRNA immunotherapies Platte will start at the mRNA immunotherapy company on 3 June Idifarma announces new Director of Operations Daniel Rivero will join the Spanish CDMO from 3P Biopharmaceuticals Buhler Group adds former Rehau Group CEO to Board Rainer Schulz will be a new member of the Board of Directors Immodulon appoints new CSO Effective immediately Thomas Kleen will take on the role within the senior management team Dr William F Feehery is new Certara CEO Effective 3 June, Dr William F Feehery will take over the model-informed drug development services company Prudential family leadership goes to third generation John Clark, son of departing CEO, Dan Clark, and third generation family member, will assume the CEO position Asceneuron appoints new Board Member Dr Eric Yuen will join the company and help initiate later stage clinical development in the tau pathology space Mogrify appoints new CBO and COO New executives at the biopharma company will be Dr Karin Schmitt as Chief Business Officer and Joe Foster as Chief Operating Officer Almac Group appoints Dr Sheryl Foster as Vice President of Quality Metrion Biosciences appoints new CEO The promotion of Dr Andrew Southan from COO is effective immediately PCI Pharma Services announces organisation updates Scancell establishes clinical advisory board Board will provide the necessary guidance as cancer immunotherapy company prepares for its lead Moditope candidate to enter the clinic in 2020 Evox hires two experienced new VPs Bo Kara will take over VP of Process Development and Simon Dew will be VP of Business Development ABPI names Novartis MD Haseeb Ahmad as President

Trending Articles